ENOPARİN 10000 ANTİ-XA IU/1 ML
Product Description
Polifarma
-
TR -
2015On CPHI since
-
3Certificates
-
1000 - 4999Employees
Company types
Primary activities
Categories
Specifications
Polifarma
-
TR
-
2015On CPHI since
-
3Certificates
-
1000 - 4999Employees
Company types
Primary activities
More Products from Polifarma (54)
-
Product ASİMPLEX 250 MG LYOPHILIZED POWDER FOR SOLUTION FOR INFUSION
Herpes simplex infections in immunosuppressed patients: ASİMPLEX is indicated for the treatment of initial and recurrent cutaneous and mucosal herpes simplex (HSV1 and HSV2) in immunocompromised individuals and immunosuppressed patients. In initial infection of genital herpes: ASİMPLEX is indicated for ... -
Product BRADİKANT 30 MG/3 ML SOLUTION FOR S.C. INJECTION IN PRE-FILLED SYRINGE
BRADİKANT is indicated for symptomatic treatment of acute attacks of hereditary angioedema (HAE) in adults, adolescents and children aged 2 years and older, with C1- esterase-inhibitor deficiency. -
Product CİPROPOL 2 MG/ML SOLUTION FOR I.V. INFUSION
In the presence of acute bacterial sinusitis, uncomplicated urinary infection and alternative treatment options, it should not be used due to the risk of serious side effects. In these indications, it can only be used with the approval of an infectious diseases specialist if it is proven with an antibio... -
Product CORTIPOL 20 MG I.M./ I.V. POWDER AND SOLVENT FOR PREPARING INJECTION/INFUSION SOLUTIONS
CORTİPOL is indicated to treat any condition in which rapid and intense corticosteroid effect is required such as: Endocrine disorders: Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoi... -
Product CORTIPOL 40 MG I.M./ I.V. POWDER AND SOLVENT FOR PREPARING INJECTION/INFUSION SOLUTIONS
Each ampoule contains 250 mg methylprednisolone sodium succinate equivalent to 188.5 mg methylprednisolone. Solvent ampoule contains 4 ml water for injection. Excipient(s): Sodium phosphate dibasic (anhydrous) ................. 7.0 mg Sodium chloride ...................................................... -
Product DEKSTOMİD 200 MCG/2 ML CONCENTRATED SOLUTION FOR I.V. INFUSION
DEKSTOMİD is indicated for the sedation of patients who are intubated and mechanically ventilated since the beginning of their treatment at intensive care units. DEKSTOMİD should be administered as an infusion continuously for a maximum of 24 hours -
Product ENOPARIN 2000 ANTİ-XA IU/0,2 Ml
ENOPARIN 2000 ANTİ-XA IU/0,2 Ml -
Product ENOPARİN 4000 ANTİ-XA IU/0,4 ML
ENOPARİN 4000 ANTİ-XA IU/0,4 ML -
Product ENOPARİN 6000 ANTİ-XA IU/0,6 ML
ENOPARİN 6000 ANTİ-XA IU/0,6 ML -
Product ESSİUM 40 MG POWDER FOR SOLUTION FOR I.V. INJECTION/INFUSION
Each vial contains 42,5 mg esomeprazole sodium equivalent to 40 mg esomeprazole. -
Product SOLUTION FOR POLYFLEX 5% DEXTROSE - 0,9% SODIUM CHLORIDE I.V. INFUSION
SOLUTION FOR POLYFLEX 5% DEXTROSE - 0,9% SODIUM CHLORIDE I.V. INFUSION -
Product FLUSİBLE 500 MG/5 ML SOLUTION FOR I.V. INJECTION
1 ml of solution contains 113,2 mg of fluorescein sodium equivalent to 100 mg of fluorescein.
The 5 ml solution contains 566 mg fluorescein sodium equivalent to 500 mg fluorescein.
The sodium content is about 5.2% (about 11,25 mmol) for each dose (from fluorescein sodium and sodium hy...
Polifarma resources (2)
Frequently Viewed Together
-
Product Remsima
The world's 1st mAb biosimilar • Ingredient: Infliximab • Indication: Rheumatoid arthritis, inflammatory bowel disease • Mode of mechanism: Relieves disease progression by inducing a neutralizing response to tumor necrosis factor(TNF-α), the cause of autoimmune disease • Approval status: 100 countri...-comp304625.png)
-
Product Romiplostim Biosimilar Candidate
Due to the complex nature of the product, Paras Biopharmaceuticals has been intensively working on this complex drug (Nplate™) for over 6 years and has progressively achieved success. The company plans to mature good value within its Romiplostim asset (Biosimilar) and would like to highlight the following...
-
Product Custom Protein Synthesis
We provide a Custom Protein Synthesis Service, using a chemical method that synthesises proteins amino acid by amino acid and making modifications on an atomic-scale. We work closely with our partners in designing, customising and optimising the proteins that is synthesized in an automa...
-
Product UV Light Blocking Tyvek Equipment Covers
UV Light Blocking Tyvek Equipment Covers are designed to keep cleaned pharmaceutical equipment and supplies clean and protected from external sources of contamination while also providing in-process protection to light sensitive biotech products.
-
Product HANDAYUAN (Adalimumab Injection)
Our first product indicated for the treatment of autoimmune diseases. HANDAYUAN (adalimumab injection) was approved by the NMPA in December 2020. It is indicated for rheumatoid arthritis, ankylosing spondylitis, plaque psoriasis, uveitis, polyarticular juvenile idiopathic arthritis, pediatric plaque ...
-
Product Ready-to Use CHO cell lines
UGA Biopharma GmbH offers to their clients so called Ready-to-use Biosimilar Cell Lines. This are in-house developed CHO cell lines stably expressing different biosimilar molecules, that are instantly available for in-licensing. The client profits, because the cell lines are directly available, and develop...
-
Product Biotechnology Services
Midas Pharma offers a wide range of pharmaceutical services which include biotechnology services. It offers: • development of biosimilars and proprietary biologicals (starting from gene sequence) • cGMP production (microbial and mammalian cells) • related bioanalytics (from protein biochemical meth...
-
Product Biosimilars Portfolio
• Pegfilgrastim (Filed with EMA) • Filgrastim (Filed with EMA) • Trastuzumab (Filed with EMA, MHRA, Received recommendation for marketing authorization in India) • Bevacizumab (Filed with MHRA) • Omalizumab (Global PhIII ongoing) • Denosumab (Global PhIII ongoing) • Ranibizumab (Global PhIII ongoing...
-
Product RARE DISEASES & ORPHAN DRUGS
Lodaat has a portfolio pipeline of Rare Disease and Orphan Drug products. USFDA in development, we are looking for partners for the US, GCC, LATAM, EU markets. Many products are made in USA products in FDA approved facilities.
-
Product Biopharmaceutical Characterisation and Testing Services
Characterization and testing of biopharmaceuticals: Using our expert's insight into a biologic's structure, physicochemical properties, potency, and impurity profile, we help you meet your development milestones.
A range of expertise is available, including assessment of structure...
-
Product Mipeginterferon alfa-2b
Pegylated human interferon alfa-2b
Trade name: PEGBING
Technology
Recombinant gene technology, expressed by Yeast
Amino acid
165 amino acids
Molecular weight
Approximately 59 kD
Indications
Chronic hepatitis B & C
...
-
Product Humodar C25 100R
PRJSC 'Indar' provides wide range of insulin products in vials and cartridges which includes humodar c25 100r. Its an anti-diabetic product of short effect. Ensures quick decrease of glucose level in the blood, intensifies its absorption by tissues. The effect starts after 30 minutes and can last within 5-...
-
Product Kemwell Biopharma
SERVICES Kemwell provides integrated development and manufacturing services for companies that require one-stop solution for mammalian cell-culture based protein therapeutics The team is experienced to undertake end-to-end activities right from cell line development till cGMP clinical and commercial manufa...
-
Product Basalin®(insulin glargine injection)
Basalin® is an insulin glargine injection developed and produced independently by Gan & Lee Pharmaceuticals. It was launched in China in 2005 and has been approved in almost 20 countries globally. As a long-acting biosimilar insulin, Basalin® is able to stablely control human blood sugar within 24...
-
Product Rituximab
Rituximab binds itself to the CD20 protein, marking them, and subsequently triggering the cells of the immune system to pick out the marked cells and kill them.The indication is for Non Hodgkin Lymphoma
-
Product Pharmaceutical and Biological Products Contract Development and Manufact...
Bora Pharmaceuticals is a premier international contract development and manufacturing organization (CDMO). Our six state-of-the-art cGMP manufacturing facilities across Asia and North America deliver to more than 100 markets around the world. Our sites have the highest industry standards for quality, dev...
-
Product Biosimilars
Portfolio of high-producing biosimilar cell lines and processes, off-the-shelf and generation of such from scratch. Biosimilarity optimisation of your recombinant cell line. Your benefit: Cost and time-savings, while bringing your product to the market. https://excellgene.com/offerings/biosimilars/
-
Product INJECTABLES
Requiring injectables.EU-GMP is a must.
EU dossier is a must.
Licensing and supply model or distributorship.
-
Product Eylea biosimilar vial & PFS
1.Completion of global clinical trials phase Ⅲ
2. Completion of pre-submission meetings with advanced regulatory authorities
3. Available in Vial and PFS
-
Product Leuprolide 3-Month Implant
The active ingredient leuprorelin, like goserelin, is a synthetic peptide that can be used primarily in the treatment of hormone-dependent tumors, particularly prostate cancer. Administration of leuprorelin has indirect effects on testosterone levels in men, the lowering of which stops the growth of malign...
-
Product Interview by Newsweek, time to talk
Interviewee：Dr. Steve J.P. Hsu (President of Genovior Biotech)
-
Product Pipeline
Polpharma Biologics has its own pipeline of biosimilars for out-licensing.
We are focused on advancing and expanding our product portfolio to increase patient access to these much-needed therapies and are open to partnering with other organizations to co-develop or commercialize our biosimilars.
-
Product Method Development
We are specialist in the method development of analytical methods for analysis of API, Final Drug Products or low level impurities. Usually followed by full validation in accordance to ICH guidelines.
-
Product Biologics
End-to-end development and manufacturing capabilities across different therapeutic modalities and the entire product lifecycle
Cutting-edge technology platforms for high yielding cell lines (both mammalian and microbial) and high concentration formulations
Integrated and flexible drug sub...
-
Product Sterile Grade at ISO Class 5 facility
Kikkoman can offer "sterile grade” products, purified through a super purification process at our ISO Class 5 facility, approved by the Japanese Authority.
-
Product Technology Transfer-Biosimilars
"If you're interested in Tech Transfer projects, our team is well-prepared to assist you with Biosimilar products such as Insulin or Monoclonal Antibodies. We have a network of over 10,000 partners who are willing to explore these opportunities. Please don't hesitate to reach out for more information on th...-comp316899.png)
-
Product Recombinant human erythropoietin injection (cho cell)
Shandong kexing bioproducts offers a wide range of products which includes recombinant human erythropoietin injection (cho cell). It is colorless and transparent liquid with ph6.9±0.5. Packaging: pre-filled syringe or vial. Storage: stored at 2-8?. Contact us for more information.
-
Product RinGlar®
Insulin glargine.
Dosage form: solution for subcutaneous injections in 3 ml cartridges and pre-filled disposable insulin pen.
· Long-acting basal insulin
· Maintains normal physi...
-
Product Biologic drug substance CDMO services
From pre-clinical development to commercial supply, Patheon by Thermo Fisher Scientific is an industry leader in the development and manufacture of mammalian cell culture drug substances. Patheon offers biotech and pharmaceutical companies the ability to pursue opportunities around the globe with a fully i...
-
Product Walk in Cooling Cabinet.
The Walk-In Cooling Cabinets / cold rooms are designed according to ICH guidelines, WHO, MCA and USFDA requirements to maintain uniform conditions. They are superior in airflow distribution, temperature control technology, cabinet construction and are manufactured as per cGMP regulations.
Biggest Walk...
-
Product Monomaterial Packaging Specialist
Pharma and Biotech toploading and sideloading cartoning systems from the monomaterial specialistDividella from Switzerland provides pharma and biotech packaging systems for the secondary packaging of parenterals. Dividella's patented top-loading and recently also side-loading cartoners package syringes, vi...
-
Product EPOMAX 2000 (RECOMBINANT HUMAN ERYTHROPOEITIN ALPHA? 2000 UI / 1 ml)
After granting the Marketing Authorization of THE FIRST Human Recombinant alpha Erythropoietin (EPO), MédiS becomes the FIRST Tunisian pharmaceutical company to produce and market its biosimilar EPO commercially appointed as EPOMAX®.
-
Product Biomedtracker
Biomedtracker provides real-time analysis of major market-moving events in the pharma and biotech industries. With catalyst tracking and expert insights, Biomedtracker helps you stay on top of breaking events, the drugs pipeline, upcoming milestones, companies, and deals – and their impact on the marke...
-
Product Anakinra Biosimilar Candidate
Paras Biopharmaceuticals has been intensively working on a Anakinra / IL1-RA biosimilar known as Kineret™) and has progressively achieved success. The company plans to mature good value within its Anakrina / IL1-RA asset and would like to highlight the following points / highlights to gauge your level of ...
-
Product Cell line development services
Cell line development services, including molecular cloning, CHO cell line development and lead clone selection, bioprocess optimization, DSP and analytical characterization of the target molecule.
-
Product Biosimilars, and High Value Molecules
Lodaat has an extensive portfolio of Biosimilars, Biologics, and High Value Molecules including ADCs, MABs and other large molecules. We are looking for reputable global partners who want to expand their product line and in-license for their territory.
-
Product Remsima SC
The 1st subcutaneous formulation of infliximab • Ingredient: Infliximab • Indication: Rheumatoid arthritis, inflammatory bowel disease • Mode of mechanism: Alleviate disease progression by inducing a neutralizing reaction to TNF-α, the cause of autoimmune disease • Approval status: 49 countries in...
-
Product Herzuma
• Ingredient: Trastuzumab • Indication: Breast cancer, stomach cancer • Mode of mechanism: Inhibits tumor cell proliferation and growth by binding to a specific antigen (HER2) that occurs specifically and excessively on the surface of tumor cells • Approval status: 80 countries including US, Euro...
-
Product HANLIKANG (Rituximab Injection)
HANLIKANG (rituximab injection) is the company's first proprietary product. It is the first-ever China-manufactured biosimilar approved by the NMPA in accordance with the Technical Guideline for the Development and Evaluation of Biosimilars (Tentative) issued in 2015. As of now, HANLIKANG has bee...
-
Product HANBEITAI (Bevacizumab Injection)
HANBEITAI (generic name: bevacizumab), the fourth product independently developed by Henlius, received marketing approval from the National Medical Products Administration (NMPA) in November 2021, and its commercialization in Chinese mainland is handled by the company's in-house team. As of now, HANBEI...
-
Product Biologic Quality Control and Release Testing
We deliver responsive QC analysis for complex biologic products from our cGMP laboratories. Our scientists develop and validate methods or perform technology transfer of a sponsor's method for a wide range of analytical methods required for batch release testing. We also routinely carry out testing to Phar...
-
Product Humodar B 100R
PRJSC 'Indar' provides wide range of insulin products in vials and cartridges which includes humodar b 100r. Its an anti-diabetic product of short effect. Ensures quick decrease of glucose level in the blood, intensifies its absorption by tissues. The effect starts after 30 minutes and can last within 5-7 ...
-
Product Biosimilars Testing Services
Testing services for biosimilars: Our biosimilar analytical comparability programs provide highly relevant data for early stage characterisation and later stage comparison. These programs evaluate and compare all pertinent features of the biosimilar product and are based on the ICH Q6B. Programs encompa...
-
Product Rasburicase Biosimilar candidate
Paras Biopharmaceuticals has been intensively working on a Romiplostim biosimilar known as Elitek™ / Fasturtec™) and has progressively achieved success. The company plans to mature good value within its Rasburicase asset and would like to highlight the following points / highlights to gauge your level of ...
-
Product Comparability Studies for Biopharmaceuticals
We design bespoke analytical programmes that ensure that the relevant quality attributes for your drug substance or product are evaluated to support your manufacturing process changes. We select analytics referenced by the ICH Q6B to examine the product's structural features (primary, secondary and&nb...
-
Product Elizaria® (eculizumab)
Paroxysmal nocturnal hemoglobinuria + atypical hemolytic uremic syndrome
-
Product CORTİPOL 250 Mg I.M./ I.V. POWDER AND SOLVENT FOR PREPARING INJECTION S...
Active Ingredient: Methyl Prednisolone Sodium Succinate
Therapeutic Area: ANTIRHEUMATIC
Recently Visited
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance